|
V83318
|
2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate
|
1050477-44-5 |
|
|
V83315
|
2-Formylbenzene-1,4-disulfonate
|
51818-11-2 |
|
|
V83319
|
6-(4-Aminophenyl)-1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxy-3-pyridazinyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
|
1589503-93-4 |
|
|
V83314
|
6-(Phthalimidomethyl)morphanthridine
|
74860-00-7 |
|
|
V83316
|
2-(Carboxymethyl)-5-methoxybenzoic acid
|
52962-25-1 |
|
|
V83317
|
(4-methoxyphenyl)methyl (6R,7R)-7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride
|
113479-65-5 |
|
|
V83320
|
3H-Imidazo[1,2-a]pyrrolo[2,3-e]pyrazine, 8-[(3R,4S)-4-ethyl-3-pyrrolidinyl]-, hydrochloride (1:2)
|
2050038-84-9 |
|
|
V83305
|
1-bromo-2-ethoxymethyl-4-h
ydroxymethylbenzene
|
1255948-71-0 |
|
|
V83302
|
4-Bromo-3-bromomethyl-benz
oic acid ethyl ester
|
347852-72-6 |
|
|
V83301
|
(2-(N-(4,5-dimethylisoxazo
l-3-yl)-N-(methoxymethyl)s
ulfamoyl)phenyl)boronic
acid
|
415697-58-4 |
|
|
V83303
|
Ethyl4-bromo-3-(ethoxymethyl)benzoate
|
948349-66-4 |
|
|
V77399
|
(+)SHIN2
|
|
(+)SHIN2 是一种丝氨酸羟甲基转移酶 (SHMT) 抑制剂,其体内靶标可通过 13C 丝氨酸进行追踪。 |
|
V77402
|
(-)SHIN2
|
|
(-)SHIN2 是 (+)SHIN2 的异构体。 |
|
V77395
|
(16R)-Epothilone D ((16R)-Epothilone; (16R)-KOS 862)
|
|
(16R)-Epothilone D 是 Epothilone D 的无活性异构体,可在实验中用作对照化合物。 |
|
V77394
|
(1R,2R)-Calhex 231 hydrochloride
|
|
(1R,2R)-Calhex 231 HCl 是 Calhex 231 HCl 的非活性异构体,可用作实验中的对照化合物。 |
|
V80091
|
(2R,3R)-Dap-NE hydrochloride
|
|
(2R,3R)-Dap-NE HCl 是五肽多拉司他汀 10 的氨基酸 (AA) 残基。 |
|
V80240
|
(2R,4R)-LY3372689
|
|
O-GlcNAcase-IN-4 是一种 O-GlcNAcase 抑制剂,可用于研究神经退行性疾病和病症,例如 AD/阿尔茨海默病。 |
|
V83298
|
(2R,4S)-N-BOC-4-Hydroxypip
eridine-2-carboxylic aci
|
321744-26-7 |
|
|
V80092
|
(2S,3R)-Dap-NE hydrochloride
|
|
(2S,3R)-Dap-NE HCl 是五肽多拉司他汀 10 的氨基酸 (AA) 残基。 |
|
V83294
|
Ruxolitinib intermediate
|
1236033-04-7 |
|